Chapter 36: Drugs Affecting Calcium and Bone Formation

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today we are tackling a subject that quite literally supports everything else we do.

That is a very good way of putting it.

We are opening up chapter 36 of

Stephen's Pharmacology to talk about drugs affecting calcium and bone formation.

It's a foundational topic in every sense of the word.

I have to admit, when I first looked at this chapter, I had a bit of a flashback to high school biology.

You know, you see the skeleton, you think structure, protection.

Maybe a museum dinosaur?

Exactly.

It feels very static.

Like once you're an adult, your bones are just the steel beams holding up the building.

They're just there.

But reading this, that assumption is completely wrong, isn't it?

It is the most common misconception we have to dismantle right at the start.

We tend to think of bone as, I know, dead rock.

But the source material makes it very clear, bone is incredibly alive.

It is a bustling construction site that never ever closes.

It's a metabolically active organ, just like your liver or your heart.

Okay, so let's break down what this living rock actually is.

The text talks about two main components.

You've got the mineral and the matrix.

Right.

And a great analogy is reinforced concrete.

You have the steel rebar, that's the organic matrix, mostly collagen proteins.

Okay, the rebar.

That gives it flexibility and tensile strength so it can bend a little without snapping.

Then you pour the concrete over it, and that's the mineral part.

And that would be the hydroxyapatite.

Precisely.

Calcium phosphate salts called hydroxyapatite, that gives it the compressional strengths, the hardness.

What's the rock part?

That's the rock.

And the process of laying that cement down is called mineralization.

But the key concept for anyone listening, and really the central theme of this entire chapter,

is remodeling.

Remodeling.

Okay, so this is the idea that we are constantly tearing down the house and rebuilding it all while we're still living in it.

That's it.

Exactly.

It is a sequential process.

You have demineralization, which is taking the calcium out, and then mineralization, which is putting it back in.

But why?

I mean, it seems so inefficient.

If I build a house, I don't start tearing down the walls the next day just for fun.

Why does the body spend so much energy destroying its own structure?

Well, there are two main reasons.

First, it's to repair micro -damage.

Every time you run, jump, or even just walk, you're creating tiny, tiny cracks in the matrix.

Remodeling fixes those before they can become big problems.

But the second reason is the most critical physiological concept in this whole introduction.

The dynamic equilibrium.

Okay, let's unpack dynamic equilibrium.

This sounds like we're moving away from structural engineering and more into banking.

That is the perfect analogy.

Think of your bones as a bank vault.

The currency is calcium.

Okay.

You have calcium floating in your blood, that's the extracellular fluid, and you have a massive reserve of calcium locked in the vault in your bones.

The body maintains a constant trade between the two.

A trade.

Yes.

The text says bone mineralization increases when blood calcium is high, so you're making a deposit into the vault.

And when it's low.

The demineralization kicks in when blood calcium is low.

You make a withdrawal.

So the bones are basically a massive savings account for calcium.

They are.

And the body is a very, very aggressive account manager.

It will make withdrawals whenever it needs to, regardless of what that does to the structural integrity of the vault itself.

That seems a little short -sighted.

Why does the body care so much about the calcium level in the blood that it's willing to dissolve its own skeleton to maintain it?

Because the stakes are immediate and life -threatening.

As the chapter highlights, proper extracellular calcium is critical for, well, almost everything.

Nerve function, muscle contraction, gland secretion, enzyme activity,

even blood coagulation.

Wow.

Okay.

If your blood calcium drops too low, your nerves start misfiring.

Your muscles can lock up.

That's a condition called tetany.

Your heart can stop beating.

Okay.

So the choice is have weak bones in 10 years or have your heart stop right now.

It's not much of a choice.

Exactly.

The body will always prioritize immediate survival.

It will sacrifice bone density today to keep the heart and nerves working today.

And that fundamental trade -off is the root of almost every pathology we're going to discuss.

That is a high stakes trade -off.

So let's look at the management team running this bank.

The text outlines three major regulators of calcium and bone metabolism.

If we look at figure 36 .1 in the book, it lays out this whole hormonal control system.

We've got three main characters, vitamin D, parathyroid hormone, and calcitonin.

Correct.

And they all have very specific jobs in this whole calcium economy.

Let's give them some job titles to help us keep them straight.

I want to start with vitamin D.

I'm thinking of vitamin D as the absorber.

That fits perfectly.

Vitamin D's primary job, physiologically, is to stimulate the absorption of calcium from the gut.

From our food.

From your food.

It increases the synthesis of a specific calcium binding protein in the duodenum and jejunum that literally pulls calcium out of what you've eaten and gets it into the system.

So without vitamin D, the calcium just passes right through us.

A lot of it does, yes.

You could drink a gallon of milk, but without enough vitamin D, you're not actually keeping much of that calcium.

But the text notes it does something else too, right?

Something that seems a little bit contradictory.

Yes.

And this is where students often get a little confused.

Vitamin D stimulates bone resorption.

So pulling calcium from the bone.

Okay.

And it stimulates bone formation.

It works on both the demolition crew and the building crew.

Why both?

That seems counterintuitive.

Because its main role is to facilitate the whole process of remodeling.

It's about turnover.

But its net effect, because it's bringing such massive amounts of calcium in from the gut, is usually to support the mineralization of bone.

It supplies the concrete for the construction site.

Okay, so vitamin D brings the supplies in.

Next up is parathyroid hormone, or PTH.

I'm calling this one the minor.

The minor is a good description, because PTH is all about getting calcium into the blood by any means necessary.

It is the primary moment -to -moment regulator.

If your calcium drops, PTH spikes.

And the text lists four specific actions of PTH that really illustrate how, as you said, aggressive this hormone is.

It's relentless.

Let's walk through those four actions carefully.

Action number one involves the kidneys.

It stimulates renal resorption of calcium.

Basically, as your blood is filtered through the kidney, some calcium naturally wants to leave in the urine.

PTH tells the kidney tubule, stop, grab that calcium, put it back in the blood, do not let it leave the building.

It's plugging the leak.

Exactly.

Okay, so it plugs the leak.

Action number two also involves the kidney, but it's about a different ion, phosphate.

And this is fascinating.

PCH decreases renal resorption of phosphate.

It tells the kidneys to actively dump phosphate into the urine.

I found this part a little confusing at first.

Why dump phosphate if the goal is to raise calcium?

Are they enemies or something?

In a chemical sense, yes.

You can think of it that way.

Imagine a seesaw.

Calcium and phosphate have a very strong affinity for each other.

If you have high phosphate in the blood, it binds up the free ionized calcium and forms a precipitate like a tiny solid crystal.

Which would lower the usable free calcium level.

Exactly.

And it could cause calcification in your soft tissues, which is very bad.

So to keep the free ionized calcium levels high, you had to keep the phosphate levels low.

PTH knows this.

So it kicks phosphate off one side of the seesaw to let calcium rise on the other.

That makes perfect sense.

It's clearing the room so calcium can be the star.

Okay, action number three.

PTH stimulates the kidneys to activate vitamin D.

Ah, a crossover episode.

It is.

It ramps up that final hydroxylation process that we'll talk about.

So PTH actually calls in the absorber for help.

It knows it can't do it all alone, so it phones a friend to get more calcium coming in from the gut.

And action number four.

This is the real minor part.

Yes, this is the direct action.

PTH stimulates osteoclasts, the bone breaking cells, to break down bone and release calcium and phosphate into that extracellular pool.

It literally dissolves the vault door to get the cash out.

So PTH is really the master regulator for keeping blood calcium up.

It stops the leak, dumps the antagonist, calls for backup, and raids the vault.

A four -pronged attack.

Now the third player is calcitonin.

I dubbed this one the stabilizer, but the text seems a little dismissive of it.

It is, in adult humans, a pretty minor player.

Calcitonin is released by the thyroid,

specifically the paraphilicular cells, when calcium gets too high.

So it does the opposite of PTH.

It does.

It inhibits bone resorption.

It essentially tells the osteoclasts to take a coffee break.

So it's the anti -PTH.

Mechanistically, yes.

But here's the kicker, and the book points this out.

People who have their thyroids removed, a thyroidectomy, they maintain calcium balance just fine without any calcitonin.

Really?

Which tells us that physiologically, in a healthy adult, it's not doing the heavy lifting.

PTH and vitamin D are the stars.

Calcitonin is pharmacologically useful as a drug, which we'll see later.

But in day -to -day life, it's not a major factor for us.

Interesting.

So we can function without the stabilizer, but we definitely can't function without the minor or the absorber.

Correct.

That's the takeaway.

Before we leave this physiology section, I want to go back to vitamin D for a second.

Figure 36 .2 traces how we actually get active vitamin D.

And it seems incredibly complicated.

I mean, why isn't the vitamin D in my fortified milk ready to work?

Why does it have to go on this cross -country road trip through my organs?

It is a journey, but it's a journey that's designed for tight regulation.

It all starts with vitamin D3, or cholecalciferol.

Cholecalciferol.

You get this from your diet, or it's synthesized in your skin from cholesterol when it's exposed to UV radiation from the sun.

But at this stage, it's biologically inactive.

It's just raw material.

So where does it go first?

First stop, the liver.

It goes to the liver, and an enzyme there adds a hydroxyl group, an oxygen and a hydrogen, at the 25th position of the molecule.

That's called calcifedial, or 25 -hydroxyvitamin D.

Is it active yet?

Not yet.

This is the main circulating storage form.

This is what doctors measure when they order a lab test to see if you're vitamin D deficient.

Just floating around in the blood waiting for orders.

And the orders come from the kidney.

Exactly.

And this is the critical control point.

The kidney contains an enzyme called 1 -alpha -hydroxylase, when PTH stimulates the kidney.

Action number three.

Action number three, exactly.

This enzyme adds another hydroxyl group, this time at the number one position.

Now, and only now, it becomes calcitrile, or 1025 -dihydroxyvitamin D.

That is the fully active hormone.

So the body intentionally separates the storage from the activation.

That prevents us from, say, getting toxic levels just because we spent a whole day at the beach.

Precisely.

You can make tons of precursor in your skin, but the kidney acts as the gatekeeper, only activating what you actually need based on that PTH signal is a beautiful system.

But there is a massive clinical connection here regarding kidney health that the text really emphasizes.

Huge.

Absolutely huge.

If a patient has chronic kidney failure, they lose functional kidney tissue, they physically lack the enzyme, that 1 -alpha -hydroxylase, to do that final activation step.

The factory's breaking.

The factory's broken.

The assembly line stops at the very last step.

So you can give these patients all the milk and sunlight in the world, but they cannot make active vitamin D.

Which leads to severe bone problems because they can't absorb calcium.

Exactly.

This is why nephrologists, kidney doctors spend half their time managing what's called renal osteodystrophy, or bone disease.

We actually have to prescribe them the already activated form of the drug,

calcitriol, which we'll discuss in the pharmacology section.

That is a crucial aha moment.

It connects the dots between renal failure and fractures.

It's a classic example of why you can't understand the drugs until you understand the physiology.

Let's move from the hormones they're giving the orders to the actual construction site.

Section 2, the bone remodeling cycle.

We've established that bone is constantly being paved and repaved.

Let's meet the crew.

We have the osteoclasts and the osteoblasts.

The names sound similar, I know, but they are mortal enemies, or maybe more accurately, essential counterparts.

Osteoclasts are the demolition crew.

Things see for crushing, collapsing, or corroding.

They resorb or break down bone.

And osteoblasts.

They are the builders.

Thank B for building.

They form new bone.

And figure 36 .3 in the text breaks down this cycle.

It's not random.

It's a very specific sequence of events.

It looks like a carefully choreographed dance.

It is.

And it has to be.

You can't pour new concrete until you've cleared away the old broken rubble.

It starts with a phase called activation.

Activation.

The osteoclasts are recruited by signal cytokines.

The text mentions things like interleukins, TNF, and a very, very important factor called rankll.

Rankll.

That sounds like one of those acronyms we definitely need to memorize.

It is.

It stands for a legand for receptor activator of nuclear factor kappa b.

Wow.

Okay.

It's a mouthful.

But conceptually, just think of rankll as the foreman on the construction site shouting, destroy.

It binds to a receptor on the osteoclast precursor cell and tells it to mature, attach to the bone, and start working.

So the osteoclasts get the signal from rankll.

They attach to the bone.

And then how do they actually break rock?

It's amazing, actually.

They create a sealed zone -like, a little suction cup against the bone surface.

Then they start pumping in hydrogen ions, which is acid and proteases.

They literally dissolve the mineral with acid and digest the protein matrix with enzymes.

They dig a pit.

A resorption pit.

Yes.

And once that pit is dug to a certain depth, the osteoclasts either die off a process called apoptosis or they just move on.

This is the reversal phase.

And interestingly, the destroyed bone matrix releases growth factors that were trapped inside it.

These growth factors are the signal that calls in the builders.

So the destruction itself calls for the reconstruction.

Exactly.

The osteoblasts arrive and they start filling that cavity with new matrix, which we call osteoid.

And then they mineralize it.

How long does this whole patch -up job take?

The whole cycle takes about 100 days on average.

But here's the critical catch.

The demolition phase is fast.

Yeah.

Maybe two weeks.

But the rebuilding.

The rebuilding phase is slow.

It takes months.

That feels like every road construction project I've ever seen.

Tearing down the old pavement is easy.

Building it back takes forever.

It's the same principle.

Yeah.

And that time discrepancy is where things can go wrong if the cycle gets out of balance.

Does this happen at the same speed everywhere in the skeleton?

Or are some parts remodeled more than others?

No.

And that's a critical distinction the book makes.

We have two main types of bone.

There's trabecular bone, which is the spongy internal mesh work you see inside of vertebra or at the end of a long bone.

Right.

And then there's cortical bone, which is the hard, compact outer shell.

Trabecular bone remodels much, much faster.

About 25 % of it is replaced annually.

25%.

Wow.

Whereas cortical bone is much slower, only about 3 % annually.

So the spongy bone is, for lack of a better word, fresher.

It is.

But because it turns over so fast, it is also more metabolically active and more sensitive to hormonal changes like PTH.

That's why osteoporosis often shows up first in areas with lots of trabecular bone, like the spine and the wrist.

The bank manager raids the most liquid assets first.

That's a great way to think about it.

And speaking of osteoporosis, the text mentions an aging shift.

What happens as we get older?

Yes.

Until your 30s or maybe early 40s, the demolition and building are perfectly balanced.

The amount of bone resorbed is equal to the amount formed?

Net zero change.

A balanced budget.

A balanced budget.

But after that, a slow, insidious imbalance begins.

Resorption starts to slightly outpace formation.

Year after year, you're digging holes that are just a tiny bit deeper than you can fill them.

Which leads us directly into section three, bone disorders.

And the big one, of course, is osteoporosis.

Poor is bone.

It's defined as a gradual reduction in bone mass that leads to an increased risk of fracture.

With minimal trauma.

And when we say minimal trauma, we aren't talking about car crashes.

No.

We're talking about falling from a standing height.

Or in severe cases, even just bending over to tie your shoes and causing a vertebral compression fracture.

Let's look at box 36 .1, the case study.

It describes a 50 -year -old postmenopausal woman.

She's worried because her mother had a hip fracture.

So her doctor orders a BMD test.

That stands for bone mineral density, right?

Correct.

Usually done with a DXA scan, which is a type of x -ray.

And what we're looking for is her T -score.

The T -score, what is that measuring?

It's a statistical comparison.

It compares her bone density to that of a healthy young adult, basically.

A human at their peak bone mass, which occurs around age 30.

So it's not comparing her to other 50 -year -olds.

It's comparing her to the best case scenario.

Exactly.

It's a measure of how far she's fallen from that peak.

So what do the numbers mean?

The text gives us some specific ranges.

Right.

A T -score of zero means you are exactly average for a young, healthy person.

A normal T -score is anything down to middle one.

That means you are within one standard deviation of the young adult mean.

Okay.

So that's the fat part of the bell curve.

Right.

Most of the population falls within that middle chunk.

Yeah.

Now, if your score is between monitor one and monitor 2 .5, that is called osteopenia.

Osteopenia.

It means low bone mass.

You're in the bottom 15 % or so.

It's a warning zone.

But if your score is less than negative 2 .5, so say negative three or negative four, that is the official diagnosis of osteoporosis.

Okay.

You are statistically way out on the tail end of the curve.

Your bones are significantly less dense than they should be.

And your fracture risk is high.

In the case study, this woman had a score of negative two.

So she has osteopenia.

Right.

She hasn't officially crossed the line into osteoporosis yet.

But because she has other risk factors, like being postmenopausal and having a family history, the physician decides to treat her preventively to stop the slide.

Why are we so aggressive about this?

I mean, a broken bone heals.

Right.

Not always.

And not without a massive cost.

The text throws out a staggering number.

The cost of hip fractures alone is projected to hit $240 billion by 2040.

Wow.

But beyond the money, a hip fracture in an elderly person is often a life -altering, catastrophic event.

It can mean a loss of independence, a move to a nursing home, and a significantly increased risk of death within a year, from complications like pneumonia or blood clots.

So we treat the numbers to prevent the catastrophe.

We treat the risk.

Absolutely.

Now briefly, there are other disorders mentioned.

Paget disease.

What's that?

Paget disease is a condition of excessive, chaotic bone turnover.

For reasons we don't fully understand, the body just goes crazy with remodeling in certain areas.

So it's remodeling on hyperdrive?

Exactly.

The osteoclasts go into overdrive, digging huge pits.

And the osteoblasts try to keep up, but they lay down this disorganized, weak, woven bone.

It leads to localized deformities, bowed legs, and enlarged skull.

And the bone is very weak and painful.

The cause is unclear.

Maybe a viral infection triggering a genetic predisposition.

And then there's the distinction between osteomalacia and rickets.

These are problems with mineralization, with the concrete pouring step.

If you have a severe vitamin D deficiency, you have the rebar, the collagen matrix, but you don't have enough calcium and phosphate to harden it.

In children, before their growth plates close, this causes rickets.

The soft bones bend under the child's weight, leading to bowed legs and other skeletal deformities.

And in adults?

In adults, the growth plates are already closed.

So the bones don't bend into new shapes, but they become soft.

This is osteomalacia.

It causes a deep, aching bone pain and significant muscle weakness.

It's rare now in many countries because we fortify milk with vitamin D, but we still see it in people with malabsorption syndromes or severe renal disease.

Okay, we've laid the foundation.

We understand the physiology, the remodeling cycle, and what happens when it breaks.

Now let's open the medicine cabinet.

Section 4, calcium and vitamin D agents.

This is the absolute first line of defense.

The text emphasizes that everyone, and I mean everyone, should meet the recommended dietary allowances.

You can't build a house without bricks and mortar.

Table 36 .1 breaks this down for us.

What are the magic numbers we should be aiming for?

For most adults, you're looking at about 1 ,000 to 1 ,200 mg of elemental calcium daily.

For vitamin D, the book cites 600 to 800 international units, or IU, per day, though it does note that many experts now argue for higher levels to maintain optimal serum concentrations.

But there's a gap highlighted here, a dietary gap.

A massive gap.

The text says most people only get about 300 mg of calcium from a non -dairy diet.

So even if you eat some cheese or yogurt, many, many people fall short of that 1 ,200 mg target.

Which is where supplements come into play, but walking down the supplement aisle is confusing.

We see calcium carbonate and calcium citrate.

Is there a real difference, or is it just marketing?

Oh, there is a very significant chemical and clinical difference.

Calcium carbonate is the most common think -tums or calcium from oyster shell.

It has the highest percentage of elemental calcium, about 40 % by weight.

But here's the crucial catch.

It requires stomach acid to be dissolved and absorbed.

So you have to take it with food?

Yes, because eating triggers acid production.

If you take it on an empty stomach, you will absorb very little of it.

What about calcium citrate?

Calcium citrate is acid -independent.

It does not require stomach acid for absorption.

This is the big expert tip from the text, especially for the elderly.

Why the elderly specifically?

As we age, our stomachs naturally produce less acid.

A condition called achlorhydria.

Or, maybe more commonly, if a patient is on a proton pump inhibitor, like omperazole for acid reflux, they have chemically neutralized their stomach acid.

So if you give those patients calcium carbonate?

It's basically an expensive placebo.

It will pass right through them.

They really, really should be on calcium citrate.

The pills are a bit bigger because it's less dense in calcium, but at least it actually gets absorbed.

That is a classic pharmacy school pearl right there.

What about side effects?

Is calcium basically harmless?

Mostly.

But the big complaint is constipation and gas.

That's number one.

Patients need to be told to increase their fiber and water intake.

More seriously, though, calcium is a sticky ion.

It binds to other drugs in the gut.

The chewing gum effect.

Exactly.

The text lists some big ones.

Ciprofloxacin, which is an antibiotic, tetracycline, and levothyroxine, the thyroid medication.

If you take your calcium at the same time as your thyroid med, the calcium binds it up, forms an insoluble complex, and you just poop it out.

So you get zero effect from the life -saving medication.

Zero.

Which is why the rule is separation.

You must take them at least two hours apart.

No exceptions.

Got it.

Now, shifting to vitamin D pharmacology.

We mentioned the three forms earlier.

Cholcalciferol is the regular vitamin D3 you buy over the counter.

Right.

That's the pro drug.

It's cheap and effective for anyone with normal liver and kidney function.

But remember, our kidney failure patient.

You can't give him D3.

Can't give him D3.

The factory's broken.

The text lists calcitriol as the prescription agent for them because it's already fully activated.

We are bypassing the broken kidney.

Are there any important interactions with vitamin D we should know about?

Yes.

The book mentions cholesterin.

It's an old cholesterol drug, a bile acid resin.

It works by binding up fats in the gut.

Since vitamin D is a fat -soluble vitamin, cholesteramine can bind it to and prevent its absorption.

Okay.

Also, certain seizure medications like phenytoin and barbiturates induce litter enzymes that chew up vitamin D much faster than normal.

So patients on those drugs often need higher doses of vitamin D to maintain their bone health.

Okay.

Let's move to the heavy hitters.

Section 5.

Bisphosphonates.

These are called the anti -resorptives.

These are the anchors of osteoporosis treatment, and the text calls them anchors for a reason.

They literally bind to the bone mineral and stay there.

The pharmacokinetic profile is just wild.

The terminal half -life in bone is greater than 10 years.

10 years?

That is mind -blowing.

You take a pill today, and traces of it are still in your skeleton a decade from now.

How do they work?

The chemistry section makes a big deal about the PCP bond.

Let's visualize this because it's key.

The body has natural molecules called pyrophosphates that regulate calcification.

Their chemical structure looks like a POP bond.

A phosphorus atom, an oxygen, then another phosphorus.

GOP.

Enzymes in the body can break that oxygen bridge very easily.

It's like a wooden door.

Easy to chop down.

Bisphosphonates are synthetic analogs.

We've replaced that central vulnerable oxygen with a carbon atom, so it becomes PCP.

That carbon bond is like a steel door.

The body's enzymes can't break it, so the drug is incredibly stable and essentially indestructible in the body.

So it sits on the bone.

Then what does it do?

It acts as a poison trap for osteoclasts.

When an osteoclast comes along and starts to dig into the bone, dissolving it, it also ingests the bisphosphonate that's stuck there.

And then?

And then it poisons the osteoclasts from the inside.

Specifically, the text says it inhibits an enzyme in the mevalinate pathway.

This is the same pathway that statins work on to lower cholesterol, but in the osteoclast, the blockade has a very different effect.

Let's decode that.

What does blocking the mevalinate pathway do to an osteoclast?

It prevents a process called preenolation of proteins.

Think of preenolation as putting little sticky feet on the signaling proteins that the osteoclast needs to function.

Without those sticky feet, the proteins can't anchor to the cell membrane.

The osteoclast's cytoskeleton, its internal scaffolding, collapses.

It can't form that sealed zone we talked about.

It loses its ruffle border and eventually undergoes apoptosis -programmed cell suicide.

So we are essentially greasing the floor so the demolition crew slips and can't do its job.

That's a great way to put it.

And because the osteoclasts are dying off, bone resorption drops dramatically.

This finally gives the osteoblasts, the builders, a chance to catch up and fill in the holes.

Now, the text mentions different generations of these drugs.

Yes, the first generation, a drug called edidrinate, was pretty weak and actually caused mineralization defects or osteomalacia.

We don't really use it much anymore.

Then what came next?

The second generation, this is allendrinate, which you may know as Phyllosomax, and pamidrinate is about 100 times more potent.

And the third generation, zoladronic acid, ibandrinate, is a staggering 1 ,000 times more potent than the first.

Let's talk about the ritual.

The patient education for taking oral bisphosphonates is famously strict.

I remember seeing this in the pharmacy.

It's not just take with food.

No, it is the exact polar opposite.

The oral absorption is terrible, less than 5%, sometimes less than 1%.

If there is any food or coffee or calcium in the stomach, the absorption drops to zero.

So what are the rules?

You must take it on a completely empty stomach first thing in the morning.

You must take it with a full glass of plain water and only plain water.

No coffee, no juice, no mineral water.

And then you wait.

And you must wait at least 30 minutes before eating, drinking anything else, or taking any of your other medications.

And there's a posture requirement too, isn't there?

Yes.

This is critical.

You must stay upright, either sitting or standing, for at least 30 minutes after swallowing the pill.

No lying down.

Why?

Why is that so important?

Because of the main side effect.

Bisphosphonates are incredibly irritating to the esophagus.

If the pill gets stuck on its way down, or if you lie down and it reflexes back up from the stomach, it can literally burn a hole in your esophagus.

It's called esophageal erosion.

It's painful and very dangerous.

So take it, wash it down thoroughly, and don't lie back down.

That is a critical safety point.

What about the other adverse effects?

The text mentions these atypical femur fractures.

This is a strange paradox.

These drugs are proven to prevent typical hip fractures.

But in rare cases of long -term use, they can cause a very unusual,

transverse break right in the middle of the shaft of the femur, the thigh bone.

Why does that happen?

The leading theory is that it's due to oversuppression of remodeling.

Remember, we need remodeling to fix those little microcracks.

If you stop the repair crew from working for 10 years, the microcracks can accumulate until the bone just snaps like a piece of chalk under normal stress.

Is there a warning sign for that?

Yes.

A dull, aching pain in the thigh or groin.

If a patient on long -term malendronate complains of thigh pain, you do not ignore it.

You get an x -ray immediately.

And the really scary sounding one?

Osteonecrosis of the jaw or ONJ?

It does sound terrifying, jawbone death.

And it is.

It's a condition where the jawbone is exposed through the gum and fails to heal.

It is rare in osteoporosis patients taking oral drugs, but we see it more often in cancer patients getting high -dose IV bisphosphonates.

And it's associated with dental work.

Strongly.

A tooth extraction is the most common trigger.

The recommendation is that patients should try to get all major dental work done before starting these drugs.

If they're already on them, they must tell their dentist.

The dentist needs to be very conservative.

Speaking of cancer, why are we using osteoporosis drugs for cancer in the first place?

The text mentions pamidrine and zolzeronic acid for this.

Many common cancers.

Breast, prostate, lung love, to metastasize to bone.

The tumors release factors that stimulate the osteoclasts to just eat away the bone around them.

This creates space for the tumor to grow and releases growth factors from the bone that actually feed the tumor.

It's a vicious cycle.

And it must be incredibly painful.

Agonizing.

And it releases tons of calcium into the blood, causing a dangerous condition called hypercalcemia.

Bisphosphonates break that cycle.

They shut down the osteoclasts, which stops the bone destruction, reduces the pain, lowers the calcium, and helps stabilize the skeleton.

Okay, moving on to section six.

We've been talking about stopping destruction.

Now let's talk about parathyroid hormone and related drugs.

This section contains the PTH paradox that always trips students up.

It is deeply counterintuitive.

We spent the first 10 minutes of this deep dive explaining that high PTH breaks down bone and causes osteoporosis.

Right.

But the drug, terapeurotide, brand name Fortio, is recombinant PTH, and we inject it to build bone.

How can the exact same molecule do opposite things?

It's all about the rhythm.

The pattern of exposure to the hormone determines the effect.

Continuous, high levels of PTH, like you see in a disease state like hyperparathyroidism, keep the osteoclasts active constantly.

The net result is bone loss.

Okay, constant exposure is bad.

But intermittent, pulsed doses, like a once -daily injection that causes a sharp spike in PTH that then clears away quickly, that preferentially stimulates the osteoblasts.

The builders.

The builders.

It wakes them up more than it wakes up the destroyers.

It increases osteoblast number and survival.

So terapeurotide is an anabolic agent.

It actually builds new bone mass.

Exactly.

This is a crucial distinction.

Bisphosphonates just preserve what you already have.

Terapeurotide builds brand new, high -quality bone structure.

It improves bone connectivity.

That sounds amazing.

Why isn't everyone on it, then?

Several reasons.

One, it's very expensive.

Two, it's a daily subcutaneous injection, which many patients dislike.

And three, there's a significant safety warning.

A black box warning for osteosarcoma.

Bone cancer?

Bone cancer.

In studies, rats that were given very high doses for a very long time developed bone tumors.

Because of this theoretical risk in humans, we limit the lifetime use of terapeurotide to just two years.

Okay.

And we never ever give it to growing children or people with pageant disease who are already at a higher baseline risk for bone turnover issues.

And there's another drug here, ablopatide.

Similar idea.

A very similar analog.

Works the same way.

Carries the same warning.

And then we have the calciumimetics, like Cinecalcet.

This works on the parathyroid gland itself.

Yes.

Cinecalcet is a very clever drug.

Think of it as a mimic, like the name says.

It mimics calcium.

It binds to the calcium sensing receptor on the parathyroid gland.

So it tricks the gland.

It completely tricks the gland into thinking, Whoa, there's plenty of calcium in the blood right now.

In response, the gland dramatically shuts down PTH secretion.

When would we use that?

In patients who have way too much PTH, but for whom we can't do surgery to remove the gland.

The classic uses are for secondary hyperparathyroidism in kidney disease, or for parathyroid cancer.

It lowers PTH and lowers calcium, all without a single incision.

Clever.

Okay.

Section seven.

We mentioned Arranchel earlier as the foreman, shouting orders to the demolition crew.

Now we have a drug that specifically hijacks that signal,

Danosumab.

This is a biologic drug, a monoclonal antibody.

If you think of Arranchelol as the key that fits into the rank receptor on the osteoclast to turn on the engine, Deenercumab is like a glob of gum you stick on the key.

It physically binds to Arranchelol and covers it up.

So if Arranchelol is bound up by the drug, it can't touch the receptor on the osteoclast.

Correct.

The foreman is gagged.

The osteoclasts never get the signal to mature.

They don't form and the existing ones die off.

Bone resorption just plummets.

How does this compare to the bisphosphonates in terms of effectiveness?

It's highly effective.

The text cites a 71 % reduction in vertebral fractures compared to placebo, which is very impressive.

It's also administered as a subcutaneous injection just once every six months.

So that's great for compliance.

It ensures 100 % compliance.

You don't have to trust the patient to stand up for 30 minutes every week.

But there's a downside mentioned related to the immune system.

Yes.

It turns out Arranchelol isn't just used by bone cells.

It's also used in the communication between immune cells, specifically T cells, and dendritic cells.

So if you block Arranchelol systemically, you can theoretically affect the immune response.

The text notes an increased risk of infections, especially skin and soft tissue infections like cellulitis.

And does it carry the same jaw and femur risks as the bisphosphonates?

It does.

Even though the mechanism of action is completely different,

the end result is the same.

A profound suppression of bone remodeling.

So ONJ and atypical femur fractures remain a risk.

We're in the homestretch here.

Section 8, other agents.

Let's do a quick round robin of the miscellaneous tools in the bag.

First up, calcitonin.

We use salmon calcitonin as the book notes because it is 40 times more potent than the human version.

From salmon.

From salmon.

It binds directly to receptors on osteoclasts,

increases an intracellular messenger called CAN -OP, and that signal basically tells the cell to stop working.

It lifts its ruffled border off the bone.

Is it a strong drug for osteoporosis?

Not really.

Tachyphylaxis, which means tolerance develops very quickly, but it has a unique benefit.

It appears to have a central analgesic effect.

It helps relieve bone pain.

Oh, interesting.

So it's great for a patient who just had an acute, painful vertebral compression fracture.

It helps the bone a little and treats the pain a lot.

Estrogen and reloxapine.

Estrogen is very protective of bone.

It suppresses the cytokines that recruit osteoclasts.

We know this because when women hit menopause and their estrogen levels plummet, bone loss accelerates dramatically.

But we don't like giving plain estrogen therapy anymore because of the risks of breast cancer and heart disease.

Exactly.

Which is where reloxapine comes in.

It's a CIRM, a Selective Estrogen Receptor Modulator.

It's a really cool pharmacology.

It binds to the estrogen receptor, but it changes the shape of that receptor differently in different tissues.

So it's a shape -shifter.

It is.

In bone, it acts like an estrogen anagonist, so it protects bone density.

That's good.

But in the breast, in the uterus, it acts as an anti -estrogen and antagonist.

So it actually reduces the risk of cancer in those tissues.

The best of both worlds.

What's the catch?

The anti -estrogen part can cause hot flashes.

And just like estrogen, it unfortunately increases the risk of blood clots thromboembolism.

So you would never give it to a smoker or someone with a history of DVT.

Sodium fluoride.

We put it in toothpaste and drinking water for our teeth.

And it's great for teeth.

It forms a substance called fluorapatite, which is much more resistant to acid and decay than regular hydroxyapatite.

But for osteoporosis, it was a massive failure.

Why?

It does stimulate osteoblasts, and it makes bone look denser on an x -ray, yes.

But the bone it makes is brittle and crystalline.

Like heap concrete.

Exactly.

It has no elasticity, no tensile strength.

Right.

Actually led to an increase in fractures, not a decrease.

So we absolutely do not use fluoride for osteoporosis.

And finally, strontium ranilate.

A fascinating drug that's used in Europe.

Strontium is a heavy element that sits right below calcium on the periodic table, so the body handles it similarly.

It seems to have a dual action.

It both inhibits resorption.

A and D stimulates formation.

Wow.

It's the only drug that seems to uncouple that process.

But it's not approved in the U .S.

due to concerns about cardiovascular risks, specifically heart attacks and clots.

All right, section nine, clinical management strategies.

Let's synthesize all of this for the listener who is thinking, okay, that's a lot of drugs.

What do I actually do for a patient with osteoporosis?

Let's follow the algorithm in the book.

Right.

For osteoporosis prevention and as a baseline treatment for everyone, the foundation is always calcium, vitamin D, and weight -bearing exercise.

You have to feed the process.

If they need a drug on top of that, what is the typical first line?

Usually an oral bisphosphonate like elendronate.

It's generic.

It's cheap.

It's effective.

And we have decades of safety data on it.

What if they can't tolerate it?

Maybe they have really bad acid reflux and just can't handle the GI side effects.

Then you look at alternatives.

Riloxafine is a good option for a post -menopausal woman, especially if she is also worried about her risk of breast cancer.

Or, denosumab, the six -month injection, is great if compliance with the oral drug rules is an issue.

What if someone has very severe bone loss, like a T -score of negative 3 .5, and they keep breaking bones even though they're on Fosamax?

Then you bring in the big guns.

You have to switch from an anti -resorptive to an anabolic agent like terapeurotide.

You actively build new bone for 18 to 24 months, and then you switch them back to an anti -resorptive like a bisphosphonate to lock in those gains.

And what about Paget disease?

Different strategy.

The goal there is to control the pain and deformity from that chaotic turnover.

Bisphosphonates are the mainstay, specifically a potent IV one like zoledronic acid.

Calcitonin is sometimes used as a backup for its pain -controlling effects.

And finally, hypercalcemia.

This is a medical emergency.

If someone comes into the ER with dangerously high calcium, maybe from a bone cancer, what's the protocol?

You have to lower that calcium immediately to save the heart and kidneys.

The very first step is hydration.

Aggressive saline diuresis.

You flood them with IV fluids to dilute the calcium and help the kidneys pee it out.

Do we use diuretics?

Loop diuretics like verosamide are sometimes used to block calcium reabsorption in the kidney, though the text notes the evidence for this is a little weak.

But the real fix is to stop the bone from releasing more calcium.

So you give them?

You give them IV disphosphonates or calcitonin to shut down the osteoclasts immediately.

And if the cause is an overactive parathyroid gland, you can use synicalcit.

Incredible.

We have mapped the entire construction site, from the hormonal blueprints to the demolition crew to the emergency repair strategies.

It's a complex system, but once you understand that fundamental balance, that seesaw between the blasts and the clasts between calcium and phosphate,

the drugs just act as logical weights that we can place on that seesaw to tip it in the right direction.

Before we sign off, we have to do our pop quiz review.

The text ends with five review questions.

I'm going to throw the scenario at you.

You give me the drug and the reason.

You ready?

I'm ready.

Let's do it.

Question one,

a drug that decreases osteoclast activation, but has a common side effect of hot flashes.

That's the serum roloxafine.

It's an estrogen agonist in bone, which stops the clasts, but an antagonist in the brain's thermoregulatory center, which is what causes the hot flashes.

Perfect.

Question two, a drug indicated for the treatment of cancer -related hypercalcemia.

Zildronic acid.

That's the potent IV bisphosphonate.

It's the fastest way to shut down the osteoclasts as the tumor is stimulating.

Question three, a drug that acts primarily by increasing the activity of osteoblasts, the builders.

That has to be terapeurotide, the anabolic PTH analog.

It's the only one on the list that truly builds fresh bone.

Question four, a drug that increases CKAB and P levels in osteoclasts, leading to their rapid inhibition.

That's the mechanism of calcitonin.

It works directly on the clast receptor to shut them down.

And last one, question five, a drug class that can remain in the bone matrix for years after administration.

Bisphosphonates for sure.

That super stable PCP bond makes them essentially indestructible, so they become a permanent part of the bone matrix.

A perfect score.

The key takeaway for me today is just that skeletal health is not static.

It is a living, breathing, responsive process.

And whether we're using diet, exercise, or pharmacology, we're essentially just trying to keep the renovation project running smoothly as the building inevitably gets older.

And realizing that your skeleton isn't just a coat rack, it's a living organ.

That's a wrap on chapter 36.

Thanks for diving deep with us.

It's always a pleasure.

This has been the Last Minute Lecture Team, helping you hack the curriculum one chapter at a time.

See you in the next deep dive.